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There is growing epidemiologic evidence for 
adverse effects on the fetus and newborn from 
maternal prenatal exposure to ambient air pol-
lution (Glinianaia et al. 2004b; Maisonet et al. 
2004; Šrám et al. 2005). Air pollutants such as 
carbon monoxide (CO), sulfur dioxide (SO2), 
and particulate matter (PM) have been associ-
ated with increased infant mortality, particu-
larly postneonatal respiratory mortality, low 
birth weight, and preterm birth (Glinianaia 
et al. 2004a, 2004b; Maisonet et al. 2004; 
Šrám et al. 2005). Inconsistencies and uncer-
tainties remain concerning the effects of specific 
pollutants and pollutant mixtures and criti-
cal exposure periods (Ritz and Wilhelm 2008; 
Woodruff et al. 2009). There are new concerns 
that air pollution may also play a role in caus-
ing congenital anomalies, and such an effect is 
both biologically plausible and of public health 
importance (Ritz 2010). Congenital anomalies 
are a main cause of infant mortality and an 
important contributor to childhood and adult 
morbidity. Major congenital anomalies in sur-
viving infants often have serious medical and/or 
cosmetic consequences that commonly require 
surgery and lead to reduced survival rates into 
adulthood (Tennant et al. 2010). Major struc-
tural congenital anomalies are diagnosed in 
2–4% of births, but in most cases their etiology 
remains unknown (Weinhold 2009).
Recently, there has been a steep increase 
in the number of air pollution studies with 
congenital anomalies as the primary health 
outcome. The first publication appeared in 
2002 (Ritz et al. 2002), the next in 2005 
(Gilboa et al. 2005), and more have followed 
in the last few years (Dadvand et al. 2011a, 
2011b; Dolk et al. 2010; Hansen et al. 2009; 
Hwang and Jaakkola 2008; Kim et al. 2007; 
Marshall et al. 2010; Rankin et al. 2009; 
Strickland et al. 2009). Because the exist-
ing studies have few a priori hypotheses and 
tested many different pollutant–outcome 
combinations, a systematic assessment of the 
consistency of associations across studies is 
needed. Furthermore, in this rapidly evolving 
field, timely evaluation of methods and results 
of existing studies can help to inform and 
improve the design of future research. Here 
we therefore provide a systematic review of 
studies on ambient air pollution and congeni-
tal anomalies and develop recommendations 
for future research.
There have been few meta-analyses of 
other environmental exposures and risk of 
congenital anomalies (e.g., Nieuwenhuijsen 
et al. 2009) because of great variability in 
exposure assessment, outcome ascertainment, 
data analysis, and result reporting. Air pol-
lution is one area where exposure estimates 
appear reasonably comparable. To illustrate the 
  challenges faced by meta-analyses in this field 
and to offer recommendations for improve-
ment, we conducted meta-analyses for a num-
ber of air pollutant–anomaly combinations.
Materials and Methods
Search methods. We followed published 
guidelines for the reporting of this review 
and meta-analysis (Moher et al. 2009; Stroup 
et al. 2000). A bibliographic search was car-
ried out in the MEDLINE engine search 
(National Library of Medicine 2010). The 
Medical Subject Heading (MeSH) terms 
“congenital abnormalities,” “pregnancy,” 
and “air pollution” and non-MeSH terms 
“birth defect,” “congenital anomalies,” “car-
diac anomalies,” “congenital heart disease,” 
and “oral clefts” were used in the syntax. We 
also searched references in published articles 
and reviews on this topic. From this search 
we selected articles that a) were original epi-
demiologic studies; b) were written in the 
English language; c) defined all or subgroups 
of congenital anomalies, congenital malfor-
mations, or birth defects as outcome; and 
d) studied human prenatal exposure to ambi-
ent air pollution using measured concentra-
tions of air pollutants. Studies with purely 
ecologic exposure assessments (e.g.,maternal 
residence in a polluted vs. unpolluted area) 
or studies with quantitative traffic density 
data but without pollutant data (e.g., Cordier 
et al. 2004) were not included in the review. 
We identified one article unpublished at the 
time of the last MEDLINE search but now 
published (Dadvand 2011b). We searched 
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oB j e c t i v e: We systematically reviewed epidemiologic studies on ambient air pollution and congenital 
anomalies and conducted meta-analyses for a number of air pollutant–anomaly combinations.
da t a s o u r c e s a n d e x t r a c t i o n: From bibliographic searches we extracted 10 original epidemio-
logic studies that examined the association between congenital anomaly risk and concentrations of air 
pollutants. Meta-analyses were conducted if at least four studies published risk estimates for the same 
pollutant and anomaly group. Summary risk estimates were calculated for a) risk at high versus low 
exposure level in each study and b) risk per unit increase in continuous pollutant concentration.
da t a synthesis: Each individual study reported statistically significantly increased risks for some 
combinations of air pollutants and congenital anomalies, among many combinations tested. In 
meta-analyses, nitrogen dioxide (NO2) and sulfur dioxide (SO2) exposures were related to increases 
in risk of coarctation of the aorta [odds ratio (OR) per 10 ppb NO2 = 1.17; 95% confidence interval 
(CI), 1.00–1.36; OR per 1 ppb SO2 = 1.07; 95% CI, 1.01–1.13] and tetralogy of Fallot (OR per 
10 ppb NO2 = 1.20; 95% CI, 1.02–1.42; OR per 1 ppb SO2 = 1.03; 95% CI, 1.01–1.05), and 
PM10 (particulate matter ≤ 10 µm) exposure was related to an increased risk of atrial septal defects 
(OR per 10 µg/m3 = 1.14; 95% CI, 1.01–1.28). Meta-analyses found no statistically significant 
increase in risk of other cardiac anomalies and oral clefts.
co n c l u s i o n s: We found some evidence for an effect of ambient air pollutants on congenital cardiac 
anomaly risk. Improvements in the areas of exposure assessment, outcome harmonization, assess-
ment of other congenital anomalies, and mechanistic knowledge are needed to advance this field.
key w o r d s : air pollution, congenital abnormalities, pregnancy. Environ Health Perspect 
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conference proceedings in the ISI Web of 
Science (Thomson Reuters 2010) for abstracts 
of other unpublished studies, using the same 
search terms as above, but we found no other 
studies that fall into this category. 
Meta­analysis. We conducted meta-
analyses to obtain summary risk estimates for 
the association between congenital anomaly 
groups and ambient air pollutant concentra-
tions. Meta-analyses were conducted only if 
at least four studies had risk estimates [usu-
ally odds ratios (ORs)] for the same pollutant 
and comparable anomaly group. Although no 
guidelines exist as to the minimum number 
of studies for meta-analysis, we considered 
four the minimum number to justifiably run 
a meta-analysis; this corresponded to having a 
minimum of 500 cases of congenital anomaly 
included in each analysis. A list of the specific 
outcome groups used in the different studies, 
and the congenial anomaly groups considered 
comparable for the purposes of these meta-
analyses, is available in Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002946). Meta-
analyses calculated two types of summary risk 
estimates: a) for the comparison of congenital 
anomaly risk at high versus low exposure level 
in each study and b) for congenital anomaly 
risk per unit increase in continuous pollutant 
concentration. For each of these, we selected 
risk estimates from the main, confounder-
adjusted models presented in each study, not 
those of sensitivity analyses. If both single- 
and multiple-pollutant models were pre-
sented, we selected the single-pollutant model. 
If studies presented results for more than one 
pregnancy period (Hwang and Jaakkola 2008; 
Ritz et al. 2002), we selected the period most 
appropriate for the development of congenital 
anomalies and most used in the other stud-
ies: month 2 or weeks 3–8 of gestation. The 
Strickland et al. (2009) study used two groups 
of ventricular septal defects (VSDs): muscular 
and perimembranous type. We calculated the 
combined risk estimate for these two groups 
and then entered the combined estimate in 
meta-analyses. Two studies (published in 
three reports) were located in the same study 
area, covered overlapping time periods, and 
analyzed some of the same anomaly groups 
(VSDs, coarctation of the aorta, tetralogy of 
Fallot) in relation to SO2 exposure (Dadvand 
et al. 2011a, 2011b; Rankin et al. 2009). We 
entered risk estimates from these publica-
tions separately in the SO2 meta-analyses, 
never at the same time. Because the Dadvand 
et al. (2011b) substudy had risk estimates for 
other air pollutants and covered a more recent 
time period, we used this as the main analy-
sis for SO2 and considered the inclusion of 
the Dadvand et al. (2011a) and Rankin et al. 
(2009) studies to be sensitivity analyses.
In the high- versus low-exposure meta-
analysis, we selected from the published 
reports risk estimates for the fourth compared 
with the first quartile of exposure, if categori-
cal risk estimates were presented (Dadvand 
et al. 2011a, 2011b; Gilboa et al. 2005; 
Marshall et al. 2010; Rankin et al. 2009; 
Ritz et al. 2002). Some studies presented 
risk estimates only for continuous exposure 
(Hansen et al. 2009; Hwang and Jaakkola 
2008; Strickland et al. 2009); we converted 
these to the risk estimate per interquartile 
increase in exposure, using the interquartile 
ranges (IQRs) given in the reports, because 
these were considered to compare most closely 
with estimates from the categorical studies. 
Information to calculate midquartile points 
was not given in these articles, so we could 
not compare the 12.5th and 87.5th percen-
tiles. One study (Dolk et al. 2010) presented 
risk estimates for the 90th versus 10th percen-
tile exposure, calculated from a continuous 
pollutant model, and this estimate was used 
for the high versus low comparison.
Meta-analyses for continuous exposure 
summarized risk estimates per unit increase 
in pollutant concentration, assuming that 
the natural logarithm of the relative risk of 
congenital anomaly varied linearly with the 
ambient air pollutant concentration. From 
each publication we selected the risk esti-
mate per continuous unit increase in pol-
lutant concentration, if available (Dadvand 
et al. 2011a; Dolk et al. 2010; Hansen et al. 
2009; Hwang and Jaakkola 2008; Ritz et al. 
2002; Strickland et al. 2009). Three articles 
described continuous exposure estimates in 
the text but did not show the risk estimates 
(Dadvand et al. 2011b; Gilboa et al. 2005; 
Marshall et al. 2010); for these we obtained 
the continuous estimates directly from the 
authors. To allow comparison of effects 
among the different studies, units were con-
verted to 10 μg/m3 for particulate matter with 
diameter ≤ 10 μm (PM10), 10 ppb for ozone 
(O3) and nitrogen dioxide (NO2), 1 ppm for 
CO, and 1 ppb for SO2. Exposure estimations 
that were expressed in a mass per volume unit 
(e.g., micrograms per cubic meter) instead of 
parts per million, billion, or hundred million 
(pphm) were converted to parts per billion 
using the general equation at 1 atm and 25°C: 
24.45 × concentration (micrograms per cubic 
meter)/molecular weight. An exception was 
made for PM10, which was always expressed 
in micrograms per cubic meter.
We obtained summary risk estimates in 
meta-analyses using fixed- or random-effects 
models. For each pollutant–outcome analysis 
we first tested for heterogeneity in the risk 
estimates using the Q-test (Cochran 1954). 
When the result of the Q-test showed evi-
dence for heterogeneity (p < 0.1), we used a 
random effect analysis, following the method 
of DerSimonian and Laird (1986). Otherwise, 
a fixed-effect analysis was conducted using 
the Mantel–Haenszel method (Mantel and 
Haenszel 1959). Meta-analyses calculated 
summary risk estimates (ORs) weighted by 
the inverse variance of each study, taking into 
account whether a fixed or random model was 
used. We used the R statistical software pack-
age for all analyses (version 2.11.0; R Project 
for Statistical Computing 2010).
We also produced forest plots to show 
ORs from each of the individual studies 
included in the meta-analyses and the estima-
tion of the summary OR (Light and Pillemer 
1984). The sizes of the markers of each OR 
in the plots represent the relative weight each 
study contributed to the summary estima-
tion. To analyze potential for publication 
bias, we conducted a weighted Egger test, a 
linear regression in which the response is the 
estimated effect and the explanatory variable 
is a precision term (1/SE) (Egger et al. 1997). 
A large deviation from zero of the slope term 
suggests publication bias.
Results
We identified 10 studies, one divided into 
two substudies (Dadvand et al. 2011a, 
2011b), published between 2002 and 2011 
(Table 1). Four studies were conducted in the 
United States (in California, Texas, Georgia, 
and New Jersey), three in England (two in 
the northern region and one in four English 
regions including the northern region), and 
one each in Australia, Taiwan, and South 
Korea. The studies focused mainly on car-
diac anomalies (Dadvand et al. 2011a, 2011b; 
Gilboa et al. 2005; Hansen et al. 2009; Ritz 
et al. 2002; Strickland et al. 2009) and/or oro-
facial clefts (Gilboa et al. 2005; Hansen et al. 
2009; Hwang and Jaakkola 2008; Marshall 
et al. 2010; Ritz et al. 2002). Only two stud-
ies (Dolk et al. 2010; Rankin et al. 2009) 
included the full spectrum of major structural 
anomalies. The South Korean study was a pro-
spective birth cohort study that included all 
congenital anomalies as one group (14 cases) 
(Kim et al. 2007). Most other studies used 
a registry-based case–control design, select-
ing cases from routine congenital anomaly 
registries and controls from birth registries. 
One study was a registry-based cohort, using 
anomaly registries as source of case ascertain-
ment and birth registry data for denominators 
(Dolk et al. 2010). Strickland et al. (2009) 
used a time-series design to link daily expo-
sure estimates to daily congenital anomaly 
rates (for a given conception date); again, 
data on the congenital anomalies came from 
a   routine register.
Major differences are apparent in the 
diagnostic coding systems, congenital anom-
aly grouping methods, and case definitions 
among the studies [see Supplemental Material, 
Table 1 (doi:10.1289/ehp.1002946)]. The 
studies by Gilboa et al. (2005) and Hansen Vrijheid et al.
600  v o l u m e  119 | n u m b e r 5 | May 2011  •  Environmental Health Perspectives
et al. (2009) based their groupings of car-
diac anomalies and orofacial clefts on the ana-
tomic classification used in the first study by 
Ritz et al. (2002); inclusion and exclusion 
of chromosomal, syndromic, and multiple 
anomalies still differed among these studies. 
The Georgia study (Strickland et al. 2009) 
used a more detailed system of diagnostic 
codes for cardiac anomalies. The U.K. stud-
ies (Dadvand et al. 2011a, 2011b; Dolk et al. 
2010; Rankin et al. 2009) all used coding and 
grouping system based on the International 
Classification of Diseases, 9th Revision (World 
Health Organization 1975) and the minor 
anomaly exclusion criteria proposed by 
the European Surveillance of Congenital 
Anomalies (EUROCAT 2009).
In all but one study (Dadvand et al. 
2011a), exposure assessments were based on 
the routine measurements of air pollutant 
concentrations at fixed-site air pollution mon-
itoring stations. Most commonly, exposures 
were assigned using the monitoring station 
nearest to the maternal residence at the time 
of the birth. Distances of residence from the 
monitors varied and in some studies inclu-
sion of study subjects was limited by their 
distance to the monitor [e.g., 16 km in the 
Ritz et al. (2002) study, 10 km in the Rankin 
et al. (2009) study]. Number and density of 
monitors also varied, as did the maximum 
distance of subjects from the nearest monitor 
(Table 1). Dadvand et al. (2011a) developed 
a spatiotemporal model in which black smoke 
and SO2 concentrations at the maternal resi-
dence were predicted using concentrations 
measured at 56 monitors and data on traffic, 
meteorology, and land cover. The Georgia 
study (Strickland et al. 2009) differed from 
others in that temporal data from one central 
monitoring station in the county were related 
to the vulnerable window of each pregnancy 
in a time-series analysis. Nearly all other stud-
ies defined windows of pregnancy suscep-
tible to the development of the congenital 
anomalies under study (usually weeks 3–8 
of gestation) and averaged exposure over 
those windows. The Dolk et al. (2010) study 
assigned mean pollutant concentrations meas-
ured in one year (1996) to the census ward 
level of residence and was not able to estimate 
exposure in pregnancy time windows.
Most studies focused on the most com-
monly monitored air pollutants: PM10 (nine 
studies), SO2 (eight studies), NO2 (seven 
studies), CO (seven studies), and O3 (seven 
studies). Less frequently studied pollutants 
Table 1. Studies on air pollution and risk of congenital anomalies.
Reference Setting Design Case and control definition Exposure assessment
Exposure range 
in second month 
of gestation
Gestational 
period Adjustment variables
Ritz et al. 
2002
California (USA), 
four counties, 
1987–1993; 
754,030 births
Case–control  3,121 cases with cardiac 
or oral facial cleft 
defects; live births 
and fetal deaths > 20 
weeks gestations; 9,357 
controls, randomly 
selected from all births 
and fetal deaths
Average of 24-hr 
measurements of CO, 
NO2, O3, and PM10 at 
nearest monitoring 
station (within 16 km)
p25–p75: 
CO, 1.14–2.39 ppm
O3, 1.07–2.86 pphm
Months 1, 
2, and 3; 
trimesters 
2 and 3; 
3 months 
preconception 
Maternal age, race, 
education, prenatal 
care, infant sex, 
decade of birth, parity, 
birth type, season of 
conception, and other 
air pollutants 
Gilboa 
et al. 
2005
Texas (USA), 
seven 
counties, 
1997–2000; 
607,500 births
Case–control  1,719 cases with cardiac 
defects or oral clefts; live 
births and fetal deaths 
> 20 weeks gestation; 
3,667 controls, live 
births, and fetal deaths, 
frequency matched by 
vital status, year of birth, 
and county
Average hourly or daily 
concentrations of CO, 
NO2, O3, PM10, and SO2, 
measured at the nearest, 
or next nearest, monitor 
in the county (median 
distance to monitor, 
8.6–14.2 km; maximum, 
36–54 km)
p25–p75:
CO, 0.4–0.7 ppm
NO2, 1.3–2.1 pphm
O3, 1.8–3.1 pphm
PM10, 19.5–29 μg/m3
SO2, 1.3–2.7 ppb
Weeks 3–8 Maternal age, 
education, race/
ethnicity, marital 
status, illness, 
tobacco use, season 
of conception, 
plurality, parity, infant 
sex, prenatal care, and 
gravidity
Kim et al. 
2007
Seoul (South 
Korea), 
2001–2004; 
1,514 births
Birth cohort 14 cases with structural 
defects in cohort of 1,514 
births
Average PM10 
concentration from 
nearest of 27 monitoring 
stations
Mean: 
PM10, 89.7 μg/m3
Trimesters 1, 2, 
and 3
Infant sex, birth 
order, season of 
birth, maternal age, 
education, alcohol, 
and body mass index
Hwang and 
Jaakkola 
2008
Taiwan, 
2001–2003; 
721,289 births
Case–control  653 cases with cleft lip 
with or without cleft 
palate diagnosed at birth; 
6,530 controls randomly 
selected from all live 
births
Monthly average of 
continuous concentration 
of CO, NOx, O3, PM10, 
and SO2, measured at 
72 monitoring stations 
in Taiwan; inverse 
distance-weighted 
average assigned to 
each residence
p25–p75:
CO, 0.48–0.76 ppm
NOx, 16.0–23.9 ppb
O3, 24.4–30.1 pphm
PM10, 44.8–64.5 μg/m3
SO2, 2.4–5.0 ppb
Months 1, 2, 
and 3
Maternal age, plurality, 
gestational age, 
population density, 
and season of 
conception
Rankin 
et al. 
2009
Northern 
region (UK), 
1985–1990; 
242,268 births
Case–control  2,779 cases with 
congenital anomaly; live 
births and fetal deaths 
≥ 20 weeks gestation; 
15,000 controls randomly 
selected from all live and 
stillbirths
Average of daily black 
smoke and SO2 from 
all monitoring stations 
within 10 km of maternal 
residence
p25–p75:
SO2, 2.7–4.5 μg/m3
Black smoke, 1.1–2.8 
μg/m3
First trimester Birth weight, sex, and 
material deprivation
Strickland 
et al. 
2009
Georgia (USA), 
five counties, 
1986–2003; 
715,500 births
Time series 3,338 cases with 
an indication of 
cardiovascular 
malformation; all live 
births, stillbirths, and 
fetal deaths > 20 weeks
Average of daily 
measurements of CO, 
NO2, O3, PM10, and 
SO2 from one central 
monitoring station; daily 
time-series analysis 
using conception dates
IQR: 
CO, 0.3 ppm
NO2, 5.7 ppb
O3, 3.0 pphm
PM10, 14.2 μg/m3
SO2, 4.0 ppb
Weeks 3–7  Week of year, and 
cubic spline for day of 
follow-up
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were black smoke, nitric oxide (NO), nitro-
gen oxides (NOx), and particulate matter 
with aerodynamic diameter ≤ 2.5 μm (PM2.5). 
Pollutant concentration distributions showed 
different patterns across studies (Table 1); for 
example, average CO concentrations were 
highest in the California study (Ritz et al. 
2002), but O3 concentrations were highest 
in the Taiwan study (Hwang and Jaakkola 
2008). In most studies where this informa-
tion was provided, pollutant concentra-
tions did not increase by more than a factor 
of 2 between the 25th and 75th percentile 
(Table 1).
Cardiac anomalies. Cardiac anomalies 
were analyzed in seven studies. Each study 
included at least six separate cardiac anomaly 
groups [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002946)] and tested these 
against three to six pollutant groups. Each 
study reported only one or a few statistically 
significantly increased risks with increased 
exposure among the multiple associations 
tested; few of these occurred in more than 
one study: CO was related to higher risk of 
VSD in two studies, with ORs for fourth- 
versus first-quartile exposure of 2.95 [95% 
confidence interval (CI), 1.44–6.05 (Ritz 
et al. 2002)] and 1.66 [95% CI, 1.37–2.02 
(Dadvand et al. 2011b)]. The studies in 
California and Australia both reported raised 
risks of pulmonary artery and valve defects in 
association with O3 exposure [OR quartile 4 
vs. quartile 1 = 2.94; 95% CI, 1.00–6.05 
(Ritz et al. 2002); OR per 5 ppb = 2.96; 95% 
CI, 1.34–7.52 (Hansen et al. 2009)]. Various 
inverse associations (decreasing risks with 
increasing exposure) were also observed.
We conducted meta-analyses for 18 com-
binations of pollutants and cardiac anomaly 
groups for which four or more studies pub-
lished results [for summary results, see Table 2; 
for full results, see Supplemental Material, 
Table 2 (doi:10.1289/ehp.1002946)]. The 
summary risk estimates from these meta-
  analyses were generally close to one, with a 
range of summary ORs for continuous expo-
sure from 0.87 to 1.20, and for high versus 
low exposure from 0.80 to 1.23. Heterogeneity 
tests showed evidence for heterogeneity among 
studies (p < 0.10) in fewer than half of the 
analyses conducted, most consistently related 
to analyses of VSDs. Egger test p-values were 
statistically significant for only 3 of the 68 
meta-analyses we conducted (see Supplemental 
Material, Table 2), indicating that wide-scale 
publication bias is unlikely. We found statisti-
cally significantly increased summary risk esti-
mates for continuous NO2 exposure and risk 
of coarctation of the aorta (OR per 10 ppb 
= 1.17; 95% CI, 1.01–1.36) and tetralogy 
of Fallot (OR per 10 ppb = 1.20; 95% CI, 
1.02–1.42), for continuous PM10 exposure and 
atrial septal defect (ASD; OR per 10 μg/m3 = 
1.14; 95% CI, 1.01–1.28), and for continu-
ous SO2 exposure and risk of coarctation of 
the aorta (OR per 1 ppb = 1.07; 95% CI, 
1.01–1.13) and tetralogy of Fallot (OR per 
1 ppb = 1.03; 95% CI, 1.01–1.05) (Table 2, 
Table 1. continued
Reference Setting Design Case and control definition Exposure assessment
Exposure range 
in second month 
of gestation
Gestational 
period Adjustment variables
Hansen 
et al. 
2009
Brisbane 
(Australia), 
1997–2004; 
150,308 births
Case–control Cases with cardiac defects 
and clefts, stillbirths and 
live births; five matched 
controls per case
Average of daily 
measurements of CO, 
NO2, O3, PM10, and SO2 
at the monitoring site 
nearest to the center of 
small area of residence
IQR, mean: 
CO, 0.6, 1.1 ppm
NO2, 4.0, 8.2 ppb
O3, 0.5, 2.6 pphm
PM10, 4.0, 18.0 μg/m3
SO2, 0.6, 1.5 ppb
Weeks 3–8  Infant sex; matching 
variables: maternal 
age, marital status, 
indigenous status, 
parity, month of 
last menstrual 
period, area-level 
socioeconomic status, 
and distance to 
monitor
Dolk et al. 
2010
Four regions 
of England, 
1991–1999; 
759,993 births
Cohort  9,085 cases with 
chromosomal and 
nonchromosomal 
anomalies, live births and 
fetal deaths ≥ 20 weeks; 
all live and stillbirths
Annual mean 
concentrations in 1996 
of NO2, PM10, and 
SO2 for 1 × 1 km grids; 
population-weighted 
average assigned 
to census ward of 
residence 
p10–p90:
NO2, 21.5–47.8 μg/m3
PM10, 18.8–26.4 μg/m3
SO2, 3.9–15.0 μg/m3
1996 average Maternal age, 
deprivation index, 
region, and hospital 
catchment
Marshall 
et al. 
2010
New Jersey 
(USA), 
1998–2003; 
690,000 births
Case–control 717 cases with cleft lip 
and/or palate, live births; 
random sample of eligible 
nonmalformed births
Average of measurements 
of CO, NO2, O3, PM10, 
PM2.5, and SO2 at 
nearest monitor 
(maximum, 40 km; 
median, 13–20 km)
p25–p75: 
CO, 0.65–1.02 ppm
NO2, 18–30 ppb
O3, 1.5–3.3 pphm
PM10, 22–33.5 μg/m3
SO2, 3–7 ppb
Weeks 3–8 Maternal race, age, 
education, gravidity, 
alcohol use, smoking, 
season of conception, 
and infant sex
Dadvand 
et al. 
2011a
Northern 
region (UK), 
1985–1996; 
449,355 births
Case–control 2,713 cases with cardiac 
defects, live births and 
fetal deaths ≥ 20 weeks 
gestation; 9,975 controls, 
live and stillbirths
Two-stage spatiotemporal 
modeling of weekly 
averages of black smoke 
and SO2 levels (from 
56 monitors) at maternal 
residence using traffic 
data, land cover data, 
and other predictors
p25–p75: 
Black smoke, 5.93–
14.57 μg/m3
SO2, 17.6–31.2 μg/m3
Weeks 3–8  Year of birth, 
socioeconomic status, 
infant sex, season 
of conception, and 
degree of urbanity
Dadvand 
et al. 
2011b
Northern 
region (UK), 
1993–2003; 
356,767 births 
Case–control 2,140 cases with cardiac 
defects, live births and 
fetal deaths > 20 weeks 
gestation; 14,256 
controls, live and 
stillbirths
Weekly average 
measurements of CO, 
NO, NO2, O3, PM10, and 
SO2, at nearest of six 
monitoring stations in 
the region (maximum, 
56–83 km; median, 
8–12 km)
p25–p75: 
CO, 0.39–0.64 mg/m3
NO2, 29.2–38.4 μg/m3
NO, 13.3–32.5 μg/m3
O3, 33.2–42.4 μg/m3
PM10, 20.5–30.2 μg/m3
SO2, 6.8–15.0 μg/m3
Weeks 3–8  Year of birth, 
socioeconomic status, 
infant sex, season 
of conception, and 
degree of urbanity
Abbreviations: p10, 10th percentile; p25, 25th percentile; p75, 75th percentile; p90, 90th percentile.Vrijheid et al.
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Figure 1A–E). p-Values for hetero  geneity in 
these analyses showed limited evidence for 
heterogeneity (p-values between 0.1 and 0.9). 
Sensitivity analyses excluding the study with 
the largest weight from each meta-analysis 
showed that results for NO2 and tetralogy of 
Fallot and for SO2 and coarctation of the aorta 
were robust to this exclusion. The results for 
SO2 were not robust to the inclusion of the 
first Dadvand study (Dadvand et al. 2011a) 
instead of the second (Dadvand et al. 2011b) 
(Table 2); the first study by Dadvand et al. 
(2011a) also introduced significant heterogene-
ity. High versus low comparisons did not show 
evidence for increased risks for any anomaly–
pollutant combinations. The summary OR 
for high compared with low CO exposure and 
risk of ASDs was significantly reduced (OR per 
1 ppm = 0.86; 95% CI, 0.75–0.99).
Orofacial clefts. Seven studies examined 
the association between air pollutants and 
risk of cleft lip with or without cleft palate 
(Table 1). Statistically significantly increased 
risks of cleft lip with or without cleft pal-
ate were observed in relation to SO2 in two 
studies [OR per 0.6 ppb = 1.27; 95% CI, 
1.01–1.62 (Hansen et al. 2009); OR quartile 
4 vs. quartile 1 = 1.6; 95% CI, 1.1–2.2 
(Marshall et al. 2010)]. None of the studies 
reported increased risks of cleft palate alone. 
Meta-analyses summarizing risk estimates for 
exposure to five pollutants and risk of cleft 
lip with or without cleft palate and cleft pal-
ate alone were all close to one, and none 
reached statistical significance (Table 3). We 
found evidence for significant heterogeneity 
(p < 0.1) in the CO and SO2 analyses. O3 
exposure and cleft lip with or without cleft 
palate showed an association of borderline 
statistical significance (OR per 10 ppb = 1.10; 
95% CI, 0.99–1.21) (Table 3, Figure 1F).
Other congenital anomalies. Two studies 
examined a range of anomalies other than car-
diac anomalies and orofacial clefts (Dolk et al. 
2010; Rankin et al. 2009). They observed sta-
tistically significantly increased risks of ompha-
locele in relation to PM10 concentrations 
[90th vs. 10th percentile: OR = 2.17; 95% CI, 
1.00–4.71 (Dolk et al. 2010)] and of nervous 
system anomalies in relation to black smoke 
concentration [OR = 1.10/mg/m3; 95% CI, 
1.03–1.18 (Rankin et al. 2009)]. No other 
anomaly groups/subtypes were at an increased 
risk in relation to the pollutants studied.
Discussion
The evidence base for an effect of exposure to 
ambient air pollutants on congenital anom-
aly risk is small. Individual studies reported 
increased risks for some combinations of air 
pollutants and congenital anomalies, mostly 
cardiac anomalies, but these occurred among 
many associations tested in each study. Meta-
analyses suggest that NO2 and SO2 expo-
sures were related to statistically significant 
increases in risk of coarctation of the aorta 
and tetralogy of Fallot, and PM10 exposure 
to an increase in risk of ASDs; we based sum-
mary risk estimates on few studies (n = 4), 
but the total numbers of cases included were 
relatively large (between 655 and 951). Meta-
analyses found no statistically significant 
increase in risk of other cardiac anomalies 
and orofacial clefts in relation to air pollution 
exposure. This review and its meta-analysis 
raise important issues that may guide both the 
design and presentation of future studies.
A common feature of all the reviewed 
studies was the use of routine monitoring 
stations as the basis for exposure assessment. 
Exposure indices were usually calculated from 
pollutant measurements at the nearest moni-
toring station or as a distance-weighted aver-
age of measurements of all stations in the area; 
these methods apply a similar exposure to a 
relatively large geographic area and thereby 
measure predominantly community-wide vari-
ations in air pollution. This approach will be 
more appropriate for pollutants that vary at 
large geographic scale (e.g., SO2, O3) than for 
those that may have a much finer spatial dis-
tribution/resolution (e.g., CO, NO2). Traffic 
exhaust fumes are the main source of air pol-
lutants such as NO2 and PM2.5 in urban areas, 
as well as a main source of suspected caus-
ative agents for adverse birth outcomes, such 
as polycyclic aromatic hydrocarbons (PAHs) 
(Perera et al. 2003; Ritz and Wilhelm 2008). 
More precise spatial models, based on disper-
sion or land-use regression models that take 
into account local road networks and other 
predictive variables, are therefore increasingly 
being recommended and used in research on 
adverse birth outcomes (Aguilera et al. 2009; 
Gilliland et al. 2005; Madsen et al. 2010; 
Nethery et al. 2008; Ritz and Wilhelm 2008; 
Slama et al. 2007, 2008; Wu et al. 2009). 
Only one of the reviewed studies (Dadvand 
et al. 2011a) used a spatiotemporal model 
for black smoke and SO2 exposure in which 
concentrations of these pollutants were pre-
dicted from monitoring data combined with 
data from traffic, meteorology, and land use. 
Application of these types of models to future 
studies of congenital anomalies would be a 
step toward more accurate exposure assess-
ment for some of the pollutants of interest. 
Characterization and quantification of errors 
in exposure estimates from these models will 
Table 2. Summary of meta-analysis of studies on air pollutant exposures and cardiac anomalies.
Pollutant and anomaly 
combination
Total 
number 
of casesb
Continuous exposurec High versus low exposure
Studies 
includeda
Heterogeneity 
p-value
Summary OR 
(95% CI)d
Heterogeneity 
p-value
Summary OR 
(95% CI)d
CO per 1 ppm
ASDs 1, 2, 5, 6, 9 1,337 0.10 0.87 (0.72–1.05) 0.17 0.86 (0.75–0.99)
VSDs 1, 2, 5, 6, 9 3,710 < 0.001 1.14 (0.70–1.85) < 0.001 1.18 (0.82–1.69)
Conotruncal defects 1, 2, 5, 6 1,156 0.02 0.95 (0.57–1.58) 0.01 0.95 (0.62–1.44)
NO2 per 10 ppb
ASDs 2, 5, 6, 9 952 0.81 1.10 (0.91–1.33) 0.28 1.07 (0.90–1.26)
VSDs 2, 5, 6, 9 3,460 0.002 1.12 (0.87–1.44) 0.03 0.92 (0.77–1.12)
Coarctation of the aorta 2, 5, 7, 9 756 0.31 1.17 (1.00–1.36) 0.13 1.04 (0.86–1.26)
Tetralogy of Fallot 2, 5, 7, 9 704 0.22 1.20 (1.02–1.42) 0.06 1.04 (0.70–1.55)
O3 per 10 ppb
ASDs 1, 2, 5, 6, 9 1,307 0.08 1.10 (0.92–1.32) 0.31 0.99 (0.83–1.19)
VSDs 1, 2, 5, 6, 9 3,557 0.02 0.95 (0.83–1.08) 0.02 0.93 (0.73–1.18)
Conotruncal defects 1, 2, 5, 6 1,164 0.64 1.07 (0.96–1.19) 0.45 1.13 (0.89–1.42)
PM10 per 10 μg/m3
ASDs 2, 5, 6, 9 951 0.10 1.14 (1.01–1.28) 0.02 1.23 (0.91–1.67)
VSDs 2, 5, 6, 9 3,410 0.12 1.03 (0.96–1.10) 0.70 0.93 (0.84–1.02)
Coarctation of the aorta 2, 5, 7, 9 761 0.02 1.10 (0.88–1.39) 0.48 1.00 (0.79–1.26)
Tetralogy of Fallot 2, 5, 7, 9 546 0.37 1.00 (0.87–1.15) 0.02 0.91 (0.53–1.56)
SO2 per 1 ppb
ASDs 2, 5, 6, 9 909 0.01 0.96 (0.86–1.07) 0.005 1.21 (0.82–1.79)
2, 5, 6, 10e 914 0.01 0.97 (0.88–1.07) 0.02 1.27 (0.91–1.77)
VSDs 2, 5, 6, 9 3,217 0.002 1.04 (0.95–1.15) < 0.001 0.96 (0.63–1.46)
2, 5, 6, 10e 3,056 < 0.001 1.02 (0.91–1.14) < 0.001 1.08 (0.81–1.44)
2, 4, 5, 6f < 0.001 1.05 (0.76–1.46)
Coarctation of the aorta 2, 5, 7, 9 682 0.90 1.07 (1.01–1.13) 0.29 1.06 (0.89–1.27)
2, 5, 7, 10e 687 0.02 1.02 (0.91–1.15) 0.01 0.89 (0.61–1.32)
2, 4, 5, 7f 0.95 1.10 (0.92–1.31)
Tetralogy of Fallot 2, 5, 7, 9 655 0.23 1.03 (1.01–1.05) < 0.001 0.80 (0.45–1.41)
2, 5, 7, 10e 670 0.05 1.01 (0.99–1.04) 0.06 1.02 (0.75–1.39)
2, 4, 5, 7f 0.13 1.13 (0.93–1.36)
aStudies included are different in each pollutant-anomaly meta-analysis depending on the data they published. 
References are as follows: 1, Ritz et al. (2002); 2, Gilboa et al. (2005); 4, Rankin et al. (2009); 5, Strickland et al. (2009); 6, 
Hansen et al. (2009); 7, Dolk et al. (2010); 9, Dadvand et al. (2011b); 10, Dadvand et al. (2011a). bNumber of cases included 
in the continuous exposure analysis. cConversion factors: CO, 1 ppb = 1.15 μg/m3; NO2, 1 ppb = 1.88 μg/m3; O3, 1 ppb = 
1.96 μg/m3; SO2, 1 ppb = 2.62 μg/m3. dWhen heterogeneity p-value is < 0.10, the OR from random effect model is shown; 
otherwise, the OR from the fixed-effects model is shown. eSensitivity analysis using Dadvand 2011a instead of Dadvand 
2011b. fSensitivity analysis including Rankin 2009 instead of Dadvand 2011b.Air pollution and congenital anomalies
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be available from validation studies (Nethery 
et al. 2008), and efforts should be made to 
also incorporate these in evaluations of con-
genital anomaly risk. Furthermore, air pol-
lution studies of other birth outcomes have 
moved toward trying to estimate more spe-
cifically the exact pollutants responsible (e.g., 
transition metals contained in PM, PAHs, 
aromatic hydrocarbons) (e.g., Aguilera et al. 
2009; Perera et al. 2003; Slama et al. 2007), 
rather than focusing on the regulated pollut-
ants, and this would be a valuable direction for 
future congenital anomaly studies.
Nearly all the reviewed studies were based 
on registry information. In such studies, resi-
dential addresses are available only at birth, 
not in the first trimester of pregnancy, the 
most relevant period for causation of congen-
ital anomalies (Moore and Persaud 1998). 
Furthermore, residential addresses only 
account for exposures near the home, not in 
other situations thought to make an impor-
tant contribution to personal exposure, such 
as work location, commuting, and indoor air 
pollution sources (Nethery et al. 2008; Setton 
et al. 2010). However, congenital anomaly 
research in this field cannot easily move away 
from routinely registered data. Large case–con-
trol studies with good information on residen-
tial history and time–activity patterns may be 
a useful step forward, if they can be combined 
with accurate exposure assessments. Pregnancy 
cohort studies in Europe are currently pooling 
resources to study effects of air pollution and 
other birth outcomes using land-use regression 
exposure models [European Study of Cohorts 
for Air Pollution Effects (ESCAPE) Project 
2009], but few such cohorts are large enough 
to conduct meaningful analyses of congen-
ital anomalies or include thorough enough 
ascertainment of congenital anomalies among 
pregnancy terminations as well as live births. 
Information from such studies may, however, 
provide useful information about the effect of 
including information on residential mobility 
and time–activity patterns on risk estimates 
for other birth outcomes (e.g., Aguilera et al. 
2009; Chen et al. 2010; Lupo et al. 2010).
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Figure 1. Forest plots showing risk estimates for individual studies and the combined meta-analysis result. Marker sizes represent the relative weight the study 
contributed to the summary estimation. (A) NO2 and coarctation of the aorta. (B) NO2 and tetralogy of Fallot. (C) PM10 and ASDs. (D) SO2 and coarctation of the 
aorta. (E) SO2 and tetralogy of Fallot. (F) O3 and cleft lip with or without cleft palate.Vrijheid et al.
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The most difficult issue in our attempt to 
combine data from the different studies was 
the use of very different criteria for definition 
and classification of congenital anomaly sub-
groups. Moreover, we found differences in 
inclusion and exclusion of cases with other 
anomalies in the same and other organ sys-
tems, with chromosomal abnormalities, and 
with other syndromic conditions. We com-
pared the different groupings and exclusions 
used [see Supplemental Material, Table 1 
(doi:10.1289/ehp.1002946)] but found that 
in some instances it is not possible to deduce 
from the articles which inclusions and exclu-
sions were made. For our meta-analyses we 
selected a few groups of relatively comparable 
anomaly groups. However, even for these, 
studies differed in their approach to classifica-
tion. VSDs, for example, were treated as one 
anomaly group by some studies (Dadvand et al. 
2011a, 2011b; Gilboa et al. 2005; Hansen 
et al. 2009; Rankin et al. 2009; Ritz et al. 
2002), as four different anomalies by another 
(Strickland et al. 2009), and were excluded in 
yet another (Dolk et al. 2010). Notably, we 
found the largest evidence for heterogeneity 
for VSDs. In general, congenital heart defects 
form a very heterogeneous set of conditions, 
notoriously difficult to classify (Botto et al. 
2007; Strickland et al. 2008). Several classi-
fication systems have been proposed (Botto 
et al. 2007; Jacobs et al. 2007), but diagnostics 
information in routine registries may often 
not be specific enough to apply these. Further 
international harmonization efforts in this area 
[e.g., those undertaken as part of EUROCAT 
(2010) and the International Clearinghouse 
for Birth Defects (2010)] will be of great 
value. Classification of orofacial clefts is more 
straightforward than that of cardiac anomalies, 
but even here differences in exclusions have 
resulted in somewhat nonhomogeneous case 
groups for the meta-analyses. We encourage 
future studies to base their classifications and 
exclusions on those of previous studies in the 
same field, where possible.
The meta-analysis results should be inter-
preted with caution because they are based on 
few studies, and because some were subject to 
some degree of statistical heterogeneity. On 
the other hand, the total numbers of cases 
included in the meta-analyses were large, rang-
ing from 500 to > 3,700, depending on the 
anomaly group. We found significant results 
for some pollutant–cardiac anomaly com-
binations, but only two of these (NO2 and 
tetralogy of Fallot, and SO2 and coarctation of 
the aorta) were robust to the exclusion of the 
study with the largest weight, and we could 
not confirm significant findings from the con-
tinuous exposure analyses with high- versus 
low-exposure analyses. It is not clear which 
of these latter analyses is the most appropri-
ate: In continuous analyses one assumes a 
(log) linear relationship between exposure and 
outcome; in the field of congenital anomaly, 
linearity cannot automatically be assumed, 
because selective survival of more viable fetuses 
related to the same exposure may lead to non-
linearity (Ritz 2010). On the other hand, the 
high versus low analysis combines categories 
of very different exposure levels across studies 
and has lower power because of smaller num-
bers of cases in these more extreme exposure 
  categories. We recommend that studies report 
both types of analyses, in annexes of sensitiv-
ity analyses where appropriate, in order to aid 
future meta-analyses.
Heterogeneity in the studies we reviewed 
may arise from inherent differences between 
the study settings, as well as from differences 
in study designs and analysis methods. First, 
the study areas were different with respect to 
exposure levels and ranges, pollutant mixtures, 
and underlying anomaly risks; this may have 
given rise to different dose–response relation-
ships. With respect to study design, we consid-
ered the assessment of exposure to be relatively 
similar: Studies assessed mostly the same pol-
lutants, same exposure windows, and similar 
distance-based exposure indices. Heterogeneity 
in our analyses was not particularly related to 
studies that deviated from the rest with respect 
to their approach to exposure assessment such 
as the Strickland et al. (2009) study with a 
purely temporal exposure model and the Dolk 
et al. (2010) study with a purely spatial model. 
As described above, ascertainment and classifi-
cation of congenital anomalies differed greatly 
among studies, and this may well have played a 
role in the observed heterogeneity. Because all 
reviewed studies used routinely registered data, 
selection and recall biases likely did not play 
a large role in most of the reviewed studies. 
However, two of the reviewed studies (Gilboa 
et al. 2005; Hansen et al. 2009) matched con-
trols to cases by, respectively, mother’s county 
of residence and mother’s distance of resi-
dence from an air pollution monitor. This may 
introduce bias by reducing exposure contrast 
between cases and controls.
Covariates included in analyses differed 
and residual confounding structures may 
differ among the studies, thus leading to 
hetero  geneity in study results. However, the 
number of known risk factors for congenital 
anomalies is extremely small, and none of 
the suspected risk factors, such as smoking, 
alcohol, folate deficiency, or socioeconomic 
status, are likely to explain a large propor-
tion of cases. Maternal smoking, for example, 
has been established as a risk factor for oro-
facial clefts with relative risk estimates around 
1.2–1.3 (Lie et al. 2008; Little et al. 2004; 
Meyer et al. 2004), but evidence for an associ-
ation with risk of other congenital anomalies 
is weak (EUROCAT 2004). Only two of the 
reviewed studies controlled for tobacco smok-
ing (Gilboa et al. 2005; Marshall et al. 2010).
Possible mechanisms of teratogenicity of 
air pollutants at this stage remain speculative, 
but several mechanisms have been hypothe-
sized for effects of PM on fetal growth, 
including oxidative stress, placental inflamma-
tion, and changes in coagulation, as reviewed 
by Kannan et al. (2006). Congenital anoma-
lies may be induced through similar effects on 
early fetal growth, as well as by air pollutants 
influencing the migration and differentiation 
of neural crest cells, by interactions with the 
metabolism and detoxification of other xeno-
biotics, or by indirect effects through mater-
nal immunologic reactions, such as infection 
or asthma, or medication related to these 
Table 3. Summary of meta-analysis of studies on air pollutant exposures and orofacial clefts.
Pollutant 
and anomaly 
combination
Total 
number 
of casesb
Continuous exposurec High versus low exposure
Studies 
includeda
Heterogeneity 
p-value
Summary OR 
(95% CI)d
Heterogeneity 
p-value
Summary OR 
(95% CI)d
CO per 1 ppm
Cleft lip/palatee 1, 2, 3, 6, 8 1,498 0.03 0.89 (0.66–1.20) 0.002 0.99 (0.79–1.24)
Cleft palate 1, 2, 6, 8 697 0.009 0.68 (0.36–1.25) 0.06 0.78 (0.55–1.12)
NO2 per 10 ppb
Cleft lip/palate 2, 6, 7, 8 1,423 0.44 0.99 (0.90–1.10) 0.25 1.06 (0.88–1.28)
Cleft palate 2, 6, 7, 8 809 0.29 0.98 (0.85–1.13) 0.23 0.79 (0.62–1.01)
O3 per 10 ppb
Cleft lip/palate 1, 2, 3, 6, 8 1,950 0.20 1.10 (0.99–1.21) 0.22 1.06 (0.96–1.17)
Cleft palate 1, 2, 6, 8 702 0.79 0.99 (0.84–1.18) 0.42 1.00 (0.79–1.26)
PM10 per 10 μg/m3
Cleft lip/palate 2, 3, 6, 7, 8 2,072 0.70 1.01 (0.96–1.06) 0.45 1.02 (0.94–1.11)
Cleft palate 2, 6, 7, 8 803 0.10 0.97 (0.82–1.16) 0.15 0.86 (0.70–1.07)
SO2 per 1 ppb
Cleft lip/palate 2, 3, 6, 7, 8 1,976 0.06 0.99 (0.95–1.04) 0.01 1.06 (0.87–1.29)
2, 3, 4, 6, 7, 8f 0.02 1.06 (0.89–1.27)
Cleft palate 2, 6, 7, 8 764 0.30 1.01 (0.99–1.03) 0.17 0.94 (0.81–1.10)
aReferences are as follows: 1, Ritz et al. (2002); 2, Gilboa et al. (2005); 3, Hwang and Jaakkola (2008); 4, Rankin et al. 
(2009); 6, Hansen et al. (2009); 7, Dolk et al. (2010); 8, Marshall et al. (2010). bNumber of cases included in the continuous 
exposure analysis. cConversion factors: CO, 1 ppb = 1.15 μg/m3; NO2, 1 ppb = 1.88 μg/m3; O3, 1 ppb = 1.96 μg/m3; SO2, 
1 ppb = 2.62 μg/m3. dWhen heterogeneity p-value is < 0.10 the OR from random effect model is shown; otherwise, the OR 
from the fixed-effect model is shown. eCleft lip with or without cleft palate. fSensitivity analysis including Rankin 2009 (no 
continuous exposure estimate available).Air pollution and congenital anomalies
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conditions (Dolk et al. 2010; Ritz et al. 2002; 
Sram et al. 2005). In animal studies, maternal 
exposure to O3, NO2, and CO has produced 
embryotoxic effects, as well as teratogenic 
effects such as skeletal and neuromuscular 
anomalies (Garvey and Longo 1978; Kavlock 
et al. 1979; Longo 1977; Singh 1988).
Genetic polymorphisms in developmental 
and detoxification genes have been described 
as potentially increasing individual susceptibil-
ity to the teratogenic effects of maternal smok-
ing (e.g., Chevrier et al. 2008; Lammer et al. 
2005); evaluation of similar gene–  environment 
interactions may aid mechanistic understand-
ing in future studies of air pollution and con-
genital anomalies. Interactions between PM 
and specific micro- and macronutrients in 
the diet (antioxidants, antiinflammatory fac-
tors) have been proposed to play a role in the 
causation of low birth weight, fetal growth 
restriction, and preterm birth, through joint 
oxidative stress and inflammatory mecha-
nisms (Jedrychowski et al. 2010; Kannan et al. 
2006); such interactions also warrant explora-
tion in the causation of congenital anomalies.
Recommendations
This review of 10 studies finds some evidence 
of an effect of air pollutants on congenital 
anomaly risk, so it is worth considering direc-
tions for further research in this area. Air pol-
lution is a ubiquitous exposure, and small 
increases in risk may therefore carry a large 
public health implication; congenital anoma-
lies are rare but serious outcomes that have a 
large impact on infant mortality and morbid-
ity and on morbidity in later life. The statisti-
cally significant increases in relative risk we 
observed in meta-analyses were between 3% 
and 20% per unit of exposure. Exposure units 
used were of the same order of magnitude as, 
or well within, the IQRs of these pollutants in 
most study areas (Table 1). Therefore, relative 
risk increases of this order of magnitude may 
be considered important for public health. 
Existing studies have so far not used some of 
the recent advances in exposure assessment 
used in other areas of air pollution research. A 
case can thus be made for well-designed stud-
ies that can make improvements in at least 
some of the following areas.
Exposure assessment. As outlined above, 
exposure indices with better spatial accuracy 
(while maintaining an accurate temporal 
component) should be used to assess exposure 
to traffic-related air pollution, because this 
is the main source of air pollution in urban 
areas. Better identification of the effects of 
specific exposures and exposure mixtures, 
and the integration of mobility and time– 
activity patterns, is recommended for congen-
ital anomaly research in the same way as for 
other birth outcomes. Matching of cases and 
controls by exposure-related variables such as 
maternal area of residence should be avoided 
in future studies.
Outcome harmonization. International 
harmonization of coding and classification of 
anomalies would greatly aid future systematic 
evaluations in this field. Any future studies 
should carefully report the exact classifications 
and exclusions used and attempt to use the 
same classifications as previous studies, at least 
in sensitivity analyses.
Other congenital anomalies. Many of 
the above studies focused on cardiac anoma-
lies and orofacial clefts. These are two of the 
largest anomaly groups, and they have been 
suspected to be related to other environ-
mental exposures (Dolk and Vrijheid 2003). 
However, studies with sufficient statistical 
power should also focus on other anomalies 
for which there may be an environmental eti-
ology (e.g., neural tube defects, limb defects, 
gastroschisis) (EUROCAT 2004).
Mechanisms and individual susceptibility. 
Improved knowledge on potential mecha-
nisms of teratogenic action of air pollutants is 
needed; this may be achieved by the integra-
tion of mechanistic biomarkers. Evaluation 
of interactions with genetic polymorphisms 
and dietary factors may also provide further 
insights into mechanisms.
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